{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T17:45:53Z","timestamp":1759340753130,"version":"build-2065373602"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.jaad.2006.01.056","type":"journal-article","created":{"date-parts":[[2006,6,16]],"date-time":"2006-06-16T08:06:08Z","timestamp":1150445168000},"page":"75-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Clinical and histopathologic observations of the action of imiquimod in an epithelioid hemangioendothelioma and Paget's mammary disease"],"prefix":"10.1016","volume":"55","author":[{"given":"Ignacio","family":"Sanchez-Carpintero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria I.","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Martin C.","family":"Mihm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2006.01.056_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1067\/mjd.2000.107809","article-title":"Imiquimod: an immune response modifier","volume":"43","author":"Dahl","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.01.056_bib2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0008-8749(02)00517-8","article-title":"Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod","volume":"218","author":"Gibson","year":"2002","journal-title":"Cell Immunol"},{"key":"10.1016\/j.jaad.2006.01.056_bib3","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/ni758","article-title":"Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway","volume":"3","author":"Hemmi","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaad.2006.01.056_bib4","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jaad.2004.02.022","article-title":"Imiquimod 5% cream for the treatment of actinic keratosis: results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology","volume":"51","author":"Szeimies","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.01.056_bib5","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.jaad.2003.11.066","article-title":"Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies","volume":"50","author":"Geisse","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2006.01.056_bib6","doi-asserted-by":"crossref","first-page":"S229","DOI":"10.1067\/mjd.2002.126584","article-title":"Treatment of primary limited cutaneous extramammary Paget's disease with topical imiquimod monotherapy: two case reports","volume":"47","author":"Zampogna","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.01.056_bib7","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1046\/j.1365-2133.2000.03787.x","article-title":"Imiquimod: a novel treatment for lentigo maligna","volume":"143","author":"Ahmed","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2006.01.056_bib8","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1001\/archderm.139.3.273","article-title":"Topical imiquimod in the treatment of metastatic melanoma to skin","volume":"139","author":"Wolf","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2006.01.056_bib9","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1159\/000066428","article-title":"Successful treatment of chronic discoid lupus erythematosus of the scalp with imiquimod","volume":"205","author":"Gerdsen","year":"2002","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2006.01.056_bib10","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1046\/j.1365-2133.2002.4653_8.x","article-title":"Porokeratosis of Mibelli: successful treatment with 5% imiquimod cream","volume":"146","author":"Agarwal","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2006.01.056_bib11","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1128\/AAC.45.4.1137-1142.2001","article-title":"Identification of genes induced by a macrophage activator, S-28463, using gene expression array analysis","volume":"45","author":"Buates","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jaad.2006.01.056_bib12","first-page":"1101","article-title":"Topical immunomodulation in dermatology: potential of toll-like receptor agonists","volume":"30","author":"Hengge","year":"2004","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2006.01.056_bib13","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/archderm.138.7.881","article-title":"Infantile hemangioma: a clinical resolution with imiquimod 5% cream","volume":"138","author":"Mart\u00ednez","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2006.01.056_bib14","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1172\/JCI117241","article-title":"Cellular markers that distinguish the phase of hemangioma during infancy and chilhood","volume":"93","author":"Takahashi","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaad.2006.01.056_bib15","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1046\/j.1523-1747.2003.12521.x","article-title":"Topical applied imiquimod inhibits vascular tumor growth in vivo","volume":"121","author":"Sidbury","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2006.01.056_bib16","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/jnci\/djg016","article-title":"Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod","volume":"95","author":"Schon","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jaad.2006.01.056_bib17","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1549-8719.1998.tb00068.x","article-title":"Increased apoptosis coincides with onset of involution of infantile hemangioma","volume":"5","author":"Razon","year":"1998","journal-title":"Microcirculation"},{"key":"10.1016\/j.jaad.2006.01.056_bib18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1365-4632.2004.02318.x","article-title":"Imiquimod is a strong inhibitor of tumor cell-induced angiogenesis","volume":"44","author":"Majewski","year":"2005","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2006.01.056_bib19","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/jcp.10235","article-title":"Mast cell-mediated apoptosis of endothelial cells in vitro: a paracrine mechanism involving TNF-alpha-mediated down-regulation of bcl-2 expression","volume":"195","author":"Latti","year":"2003","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.jaad.2006.01.056_bib20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1523-1747.2000.00833.x","article-title":"Imiquimod, a topical immune response modifier, induces migration of Langerhans cells","volume":"114","author":"Suzuki","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2006.01.056_bib21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1006\/cimm.2000.1673","article-title":"The immune response modifiers imiquimod and R-848 are potent activators of B lymphocytes","volume":"203","author":"Tomai","year":"2000","journal-title":"Cell Immunol"},{"key":"10.1016\/j.jaad.2006.01.056_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1074-7613(00)80585-3","article-title":"Tumor cell responses to IFN gamma affect tumorigenicity and response to IL-12 therapy and antiangiogenesis","volume":"9","author":"Coughlin","year":"1998","journal-title":"Immunity"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096220600315X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096220600315X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:03:58Z","timestamp":1759269838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019096220600315X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S019096220600315X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2006.01.056","relation":{},"ISSN":["0190-9622"],"issn-type":[{"type":"print","value":"0190-9622"}],"subject":[],"published":{"date-parts":[[2006,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and histopathologic observations of the action of imiquimod in an epithelioid hemangioendothelioma and Paget's mammary disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2006.01.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}